Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis
- 29 August 2006
- journal article
- research article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 15 (2), 197-202
- https://doi.org/10.1007/s00520-006-0120-z
Abstract
Prevalence of bisphosphonate-associated osteonecrosis of the jaws within the catchment area of a university hospital maxillofacial unit and to review the outcome of treatment.Keywords
This publication has 38 references indexed in Scilit:
- Osteonecrosis of the jaws in patients treated with bisphosphonates – histomorphologic analysis in comparison with infected osteoradionecrosisJournal of Oral Pathology & Medicine, 2006
- Treatment of head and neck cancer in elderly patients: state of the art and guidelinesCritical Reviews in Oncology/Hematology, 2005
- Zoledronic AcidDrugs, 2004
- Bisphosphanates and Oral Cavity Avascular Bone NecrosisJournal of Clinical Oncology, 2003
- Novel Antiangiogenic Effects of the Bisphosphonate Compound Zoledronic AcidPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2002
- Avascular Necrosis of the Femoral Head in Patients with Prostate Cancer Treated with Cyproterone Acetate and RadiotherapyClinical Oncology, 2001
- Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.Journal of Clinical Investigation, 1996
- Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivoJournal of Bone and Mineral Research, 1995
- Pharmacokinetics of Pamidronate in Patients With Bone MetastasesJNCI Journal of the National Cancer Institute, 1992
- Fragilitas Ossium amongst Workers in Lucifer Match FactoriesBMJ, 1899